Ingrid Polakova - Search Results

Year	Number of Results
2007	1
2008	2
2009	2
2010	1
2011	1
2014	2
2016	1
2018	2
2019	2
2020	1
2021	2
2023	0

1

Combined Cancer Immunotherapy Against Aurora Kinase A.

Kaštánková I, Poláková I, Dušková M, Šmahel M. Kaštánková I, et al. Among authors: polakova i. J Immunother. 2016 May;39(4):160-70. doi: 10.1097/CJI.0000000000000120. J Immunother. 2016. PMID: 27070447

2

Enhancement of DNA vaccine potency against legumain.

Smahel M, Duskova M, Polakova I, Musil J. Smahel M, et al. Among authors: polakova i. J Immunother. 2014 Jun;37(5):293-303. doi: 10.1097/CJI.0000000000000040. J Immunother. 2014. PMID: 24810641

3

CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade.

Vackova J, Polakova I, Johari SD, Smahel M. Vackova J, et al. Among authors: polakova i. Cancers (Basel). 2021 Apr 16;13(8):1935. doi: 10.3390/cancers13081935. Cancers (Basel). 2021. PMID: 33923750 Free PMC article.

4

Abrogation of IFN-γ Signaling May not Worsen Sensitivity to PD-1/PD-L1 Blockade.

Vackova J, Piatakova A, Polakova I, Smahel M. Vackova J, et al. Among authors: polakova i. Int J Mol Sci. 2020 Mar 6;21(5):1806. doi: 10.3390/ijms21051806. Int J Mol Sci. 2020. PMID: 32155707 Free PMC article.

5

Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors.

Poláková I, Pelák O, Thürner D, Pokrývková B, Tachezy R, Kalina T, Šmahel M. Poláková I, et al. J Immunol Res. 2019 Feb 11;2019:6705949. doi: 10.1155/2019/6705949. eCollection 2019. J Immunol Res. 2019. PMID: 30886872 Free PMC article.

6

Antitumor DNA vaccination against the Sox2 transcription factor.

Polakova I, Duskova M, Smahel M. Polakova I, et al. Int J Oncol. 2014 Jul;45(1):139-46. doi: 10.3892/ijo.2014.2402. Epub 2014 Apr 28. Int J Oncol. 2014. PMID: 24789529

7

Distinct Responsiveness of Tumor-Associated Macrophages to Immunotherapy of Tumors with Different Mechanisms of Major Histocompatibility Complex Class I Downregulation.

Piatakova A, Polakova I, Smahelova J, Johari SD, Nunvar J, Smahel M. Piatakova A, et al. Among authors: polakova i. Cancers (Basel). 2021 Jun 19;13(12):3057. doi: 10.3390/cancers13123057. Cancers (Basel). 2021. PMID: 34205330 Free PMC article.

8

Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation.

Grzelak A, Polakova I, Smahelova J, Vackova J, Pekarcikova L, Tachezy R, Smahel M. Grzelak A, et al. Among authors: polakova i. Int J Mol Sci. 2018 Nov 21;19(11):3693. doi: 10.3390/ijms19113693. Int J Mol Sci. 2018. PMID: 30469401 Free PMC article.

9

Establishment and characterization of a mouse tumor cell line with irreversible downregulation of MHC class I molecules.

Lhotakova K, Grzelak A, Polakova I, Vackova J, Smahel M. Lhotakova K, et al. Among authors: polakova i. Oncol Rep. 2019 Dec;42(6):2826-2835. doi: 10.3892/or.2019.7356. Epub 2019 Oct 4. Oncol Rep. 2019. PMID: 31638243

10

Vaccination with human papillomavirus type 16-derived peptides using a tattoo device.

Pokorná D, Poláková I, Kindlová M, Dusková M, Ludvíková V, Gabriel P, Kutinová L, Müller M, Smahel M. Pokorná D, et al. Among authors: polakova i. Vaccine. 2009 Jun 2;27(27):3519-29. doi: 10.1016/j.vaccine.2009.03.073. Epub 2009 Apr 16. Vaccine. 2009. PMID: 19464530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results